NeuroPace (NPCE) Tops Q3 EPS by 12c

NeuroPace (NASDAQ: NPCE) reported Q3 EPS of ($0.28), $0.12 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $16.4 million versus the consensus estimate of $14.23 million.

For earnings history and earnings-related data on NeuroPace (NPCE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c